Journal of Yeungnam Medical Science

Review article

Pulmonary and Respiratory Medicine
Creating home-based pulmonary rehabilitation programs for patients with asthma: insights from practice: Cahidenur Koçak, Massimiliano Polastri, Esra Pehlivan; J Yeungnam Med Sci. 2025;42:57. Published online September 17, 2025; DOI: https://doi.org/10.12701/jyms.2025.42.57

3,902 View
198 Download
1 Web of Science
2 Crossref

Pulmonary rehabilitation (PR) plays a crucial role in the management of asthma symptoms and addresses the physical, psychological, and social consequences of asthma. However, difficulties in accessing hospital-based PR programs could result in underutilization of these services. Alternative models such as home-based PR and telerehabilitation are promising in their potential to mitigate barriers and improve adherence. It is well known that PR has a significant positive impact on both respiratory and physical functions, as well as individual well-being. Indeed, such effects have been confirmed in several studies in which psychological symptoms (i.e., anxiety and depression), physical capacity, and health-related quality of life improved in patients with asthma. Nonetheless, to sustain treatment-related benefits in the long term, PR programs must be tailored to individual needs and planned using a multidisciplinary and holistic approach. Given the high prevalence of asthma in children, home-based PR programs may offer substantial benefits to the pediatric population and warrant further investigation. The present review describes the characteristics of home-based PR and provides evidence on current practices for the management of asthma and the development of a patient-centered therapeutic approach.

Citations

Citations to this article as recorded by

The Role of Adherence to Pharmacological and Non-Pharmacological Treatments in Hospitalized Patients with Obstructive Airway Diseases
Büşra Durak, Galip Koçyiğit, Hasan Can Alagöz, Canan Gündüz Gürkan
Dicle Tıp Dergisi.2026; 53(1): 67. CrossRef
Feasibility of app-based pulmonary telerehabilitation program for textile dyeing workers with respiratory symptoms: a quasi-experimental study
Myeong Geun Jeong, Gun Seo Jung, Kyoung Tae Kim
Journal of Yeungnam Medical Science.2026; 43: 20. CrossRef

Focused Review article

Pulmonary and Respiratory Medicine
Biological treatments for severe asthma: Hyun Jung Jin; Yeungnam Univ J Med. 2020;37(4):262-268. Published online September 11, 2020; DOI: https://doi.org/10.12701/yujm.2020.00647

11,467 View
195 Download
14 Crossref

Abstract PDF

Severe asthma patients comprise about 3% to 13% of all asthma patients, but they have higher hospital utilization rates and higher medical costs than those of nonsevere asthma patients. Treatment methods for severe asthma patients are still lacking; however, the recent development of biologics is expected to have a positive effect. The biological therapies developed so far are mainly aimed at treating asthma patients with type 2 inflammation. These biologics have been found to reduce symptoms of asthma, improve lung function, reduce the use of oral corticosteroids, and improve quality of life of patients. This article reviews the mechanism of action and indications for approved biologics and discusses what should be considered when choosing biologics.

Citations

Citations to this article as recorded by

Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma
Zeina Kassem, Jenny K. W. Lam, Hanieh Khalili
RSC Pharmaceutics.2026; 3(3): 630. CrossRef
Allergen Immunotherapy for the Prevention and Treatment of Asthma
Thierry Batard, Camille Taillé, Laurent Guilleminault, Andrzej Bozek, Véronique Bordas‐Le Floch, Oliver Pfaar, Walter G. Canonica, Cezmi Akdis, Mohamed H. Shamji, Laurent Mascarell
Clinical & Experimental Allergy.2025; 55(2): 111. CrossRef
Determinants of cost-effectiveness results of biological therapies for severe asthma: a systematic methodological assessment
Laura de la Torre-Pérez, Marilina Santero, Wendy Nieto-Gutierrez, Christine Giesen, Angela Nardin, Claudia Cosma, Pedro Silva Pires, Andrea Guida, Marcello Simonini, Camila Quirland Lazo, Feng Xie, Pablo Alonso-Coello
Journal of Clinical Epidemiology.2025; 178: 111621. CrossRef
Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps
Hanna K. Mandl, Jessa E. Miller, Daniel M. Beswick
Otolaryngologic Clinics of North America.2024; 57(2): 225. CrossRef
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities
Sara Naharro-González, Clara Lorente-Sorolla, José Manuel Rodrigo-Muñoz, Marcela Valverde-Monge, Erwin Javier Pinillos-Robles, Diana Betancor, Mar Fernández-Nieto, Diana Sánchez-Mellado, Marta Gil-Martínez, Jessica Mireya Santillán-Coello, José Miguel Vil
Biomolecules.2024; 14(1): 126. CrossRef
Biologic Therapies across Nasal Polyp Subtypes
Kody G. Bolk, Sarah K. Wise
Journal of Personalized Medicine.2024; 14(4): 432. CrossRef
Evaluation of multiple-flows exhaled nitric oxide and its clinical significance in severe asthmatic patients treated with biologics: a prospective real-life study
Tommaso Pianigiani, Simona Luzzi, Akter Dilroba, Martina Meocci, Elisa Salvadori, Lorenzo Alderighi, Laura Bergantini, Miriana d’Alessandro, Piersante Sestini, Elena Bargagli, Paolo Cameli
Journal of Asthma.2024; 61(12): 1619. CrossRef
Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
Chin Kook Rhee, Jung-Won Park, Heung-Woo Park, Hayeon Noh, Jerome Msihid, You Sook Cho
Allergy, Asthma & Immunology Research.2024; 16(4): 372. CrossRef
Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies
Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young, Nathorn Chaiyakunapruk
Journal of Asthma.2023; 60(9): 1702. CrossRef
Tackling the cytokine storm using advanced drug delivery in allergic airway disease
Vyoma K. Patel, Sukriti Vishwas, Rajan Kumar, Gabriele De Rubis, Shakti D. Shukla, Keshav Raj Paudel, Bikash Manandhar, Thakur Gurjeet Singh, Dinesh Kumar Chellappan, Monica Gulati, Indu Pal Kaur, Venkata Sita Rama Raju Allam, Philip M. Hansbro, Brian G.
Journal of Drug Delivery Science and Technology.2023; 82: 104366. CrossRef
The evolving landscape of immunotherapy for the treatment of allergic conditions
Aarti Pandya, Esosa Adah, Bridgette Jones, Rachel Chevalier
Clinical and Translational Science.2023; 16(8): 1294. CrossRef
Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
Chin Kook Rhee, Jung-Won Park, Heung-Woo Park, You Sook Cho
Allergy, Asthma & Immunology Research.2022; 14(2): 182. CrossRef
The role of peripheral eosinophilia in diagnosing lung disorders: experience from a single pneumonological center
Justyna Fijołek, Elzbieta Wiatr, Dorota Piotrowska-Kownacka, Kazimierz Roszkowski-Sliz
Multidisciplinary Respiratory Medicine.2021;[Epub] CrossRef
Advances in the science and treatment of respiratory diseases
Jin Hong Chung
Yeungnam University Journal of Medicine.2020; 37(4): 251. CrossRef

Original Article

Pediatrics, Perinatology, and Child Health
The clinical observations in childhood asthma.: Kih Yeon Song, Yong Hyoun Park, Jin Gon Jun, Young Hwan Lee, Chun Dong Kim; Yeungnam Univ J Med. 1992;9(2):239-247. Published online December 31, 1992; DOI: https://doi.org/10.12701/yujm.1992.9.2.239

2,326 View
2 Download

Abstract PDF: A clinical analysis was done on 134 cases with bronchial asthma who were admitted to the Department of Pediatrics Yeungnam University from May 1987 to October 1991. The results were as follows: 1) The peak age of bronchial asthma was under 2 years. The sex ratio of male to female was 2.9:1. 2) The outbreak of bronchial asthma was most common in fall, especially in September. 3) The past history of other allergic diseases were present in 22.4% of patients (30/134 cases), and the previous bronchiolitis in infancy were experienced in 12.7% of patients (17/134 cases). 4) According to the skin test for allergens done by RAST, the most common allergens were Mites and House dust. 5) Eosinophilia (T.E.C>250/min) was found in 29.1%t of patients, and elevated lgE level (>200 IU/ml) was found in 63.2% of patients. 6) No significant differences in the serum lgE level were found between male and female patients. No significant differences in the serum lgE level were found between asthma patients with and without other allergic diseases. 7) The serum lgE level of school aged patients was significant higher than that of preschool aged (p<0.01).

First
Prev
Page of 1
Next
Last

Search